- ►annals.org [PDF] C Levine, R Faden, C Grady, D … - Annals of internal medicine, 2004 - Am Coll Physicians Research participants require ongoing protection of the kind al- ready
established in law and regulation. However, “special scru- tiny” for certain
types of research is also needed. Three criteria for special scrutiny are ... Cited by 8 - Related articles - BL Direct - All 4 versions
S Scrutiny - Ann Intern Med, 2004 - litbang.depkes.go.id Research participants require ongoing protection of the kind al- ready
established in law and regulation. However, “special scru- tiny” for certain
types of research is also needed. Three criteria for special scrutiny are ... Related articles - View as HTML - All 2 versions
- ►upenn.edu [PDF] CM Ulrich, GR Wallen, A Fiester, C Grady - IRB: Ethics & Human Research, 2005 - medscape.com Mrs. C. is a 32-year-old female diagnosed with melanoma and metastasis to the
liver. She has been suffering from moderate, self-described annoying pain in the
abdominal region almost constantly for the past several weeks and self- ... Related articles - All 7 versions
HA Taylor, L Chaisson, J Sugarman - Clinical Trials, 2008 - ctj.sagepub.com Data Monitoring Committees (DMC) and Institutional Review Boards (IRB) each can
play important roles in protecting the rights and interests of research
participants and ensuring the integrity of research. While both IRBs and ... Related articles - All 3 versions
LP Cohen - Wall Street journal (Eastern ed.), 1996 - ncbi.nlm.nih.gov 1: Wall St J (East Ed). 1996 Nov 14:A1, A10. To screen new drugs for safety,
Lilly pays homeless alcoholics: it's 'quick cash' to ... Cited by 1 - Related articles
GM Zaninia, C Maroneb - smw.ch We report three years of experience with a newly introduced register for healthy
research vol- unteers in Canton Ticino, Southern Switzerland. The aim of the
register was to encourage respon- sible participation in medical research, ... Cited by 1 - Related articles - View as HTML - All 3 versions
J Sugarman, C Levine - The Lancet, 2007 - Elsevier In their scientific analysis of the disastrous TGN1412 trial, MJH Kenter and AF
Cohen (Oct 14, p 1390) 1 conclude that “the antibody was a high-risk compound
unlikely to be suitable for administration to healthy people without ... Cited by 1 - Related articles - All 3 versions
JD Moore - Clinical pharmacology and therapeutics - ncbi.nlm.nih.gov 1: Clin Pharmacol Ther. 1972 Sep-Oct;13(5):833-4. The Deer Lodge Research
Unit. Moore JD. Publication Types: Clinical Trial. Mesh ... Cited by 1 - Related articles
D Goldberg - Washington post (Washington, DC: 1974), 2002 - ncbi.nlm.nih.gov 1: Washington Post. 2002 Nov 30:A3. Artificial heart implant leads to
suit over consent process: recipient's widow says she and ... Cited by 2 - Related articles
